LIpid Response to Statins ± Ezetimibe In Mumbai (LIRIM): A Cross-sectional Observational Study
Journal of The Association of Physicians of India · 2024
DOI: 10.59556/japi.72.0622 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of The Association of Physicians of India, 2024. Verfasst von V T Shah. Beteiligte Einrichtung: Director of Cardiology, Surana Sethia Hospital, Mumbai, Maharashtra, India, Corresponding Author. Hauptthemen laut MEDLINE: Ezetimibe, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cholesterol, LDL, Anticholesteremic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Director of Cardiology, Surana Sethia Hospital, Mumbai, Maharashtra, India, Corresponding Author.
Zitieren
APA
Shah, V. T. (2024). LIpid Response to Statins ± Ezetimibe In Mumbai (LIRIM): A Cross-sectional Observational Study. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0622
Vancouver
Shah VT. LIpid Response to Statins ± Ezetimibe In Mumbai (LIRIM): A Cross-sectional Observational Study. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0622
BibTeX
@article{Shah2024,
author = {Shah, V T},
title = {LIpid Response to Statins ± Ezetimibe In Mumbai (LIRIM): A Cross-sectional Observational Study},
journal = {Journal of The Association of Physicians of India},
year = {2024},
doi = {10.59556/japi.72.0622}
}
EUVIMED